GenprexGNPX

13F holders, Q1 2024 (March 31)
16holders
$2.98avg. 13F price*

At the end of Q1 2024, 16 institutions reported holding Genprex Inc. (GNPX) in their 13F filings. The largest holders were Armistice Capital, LLC ($292K), Vanguard Group Inc. ($46K) and Geode Capital Management, LLC ($36K).

Company
Genprex Inc.
CUSIP
372446203
Latest filing quarter
Q3 2025

History

Number of 13F holders

0102030 Q1 2024: 16Q1 2024Q2 2024: 15Q2 2024Q3 2024: 21Q3 2024Q4 2024: 22Q4 2024Q1 2025: 24Q1 2025Q2 2025: 28Q2 2025Q3 2025: 20Q3 2025

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions2$292K
Exits1$4K

Ownership 16 holders

Armistice Capital, LLC 0.01% New 97,868 $292K
Vanguard Group Inc. 0.00% Reduce -66.5% 15,315 $46K
Geode Capital Management, LLC 0.00% Reduce -2.7% 11,991 $36K
BlackRock Inc. 0.00% No change 11,394 $34K
Tower Research Capital LLC (TRC) 0.00% Add +684.7% 2,765 $8K
Morgan Stanley 0.00% Add +0.6% 1,495 $4K
Group One Trading LLC 0.00% Add +0.2% 828 $2K
UBS Group AG 0.00% Reduce -45.2% 591 $2K
Bank of America Corp. 0.00% Add +8243.4% 413 $1K
Nemes Rush Group LLC 0.00% New 250 $745
Wells Fargo & Company 0.00% Add +3.5% 11 $33
JPMorgan Chase & Co. 0.00% Reduce -26.2% 5 $15
Signaturefd, LLC 0.00% Add +400.0% 1 $3
Osaic Holdings, Inc. 0.00% Reduce -99.8% 1 $2
Royal Bank of Canada 0.00% Add +13.4% 98 $0
VitalStone Financial, LLC 0.00% No change 10 $0

"% of holder's portfolio" is GNPX's weight in each manager's 13F, not the share of Genprex Inc. the manager owns.